IMM 1.27% 40.0¢ immutep limited

sunday morning reflection and reality

  1. 108 Posts.
    Hi Fellow PRR Holders

    Gee there is a fair bit of excitement ATM. We have the rampers/dampers - we have the chartists - we have the believers - ALL GOOD STUFF.

    I have been in the market a long long time and boy I have made some mistakes some really dumb mistakes. However, I have also made some really good investment decisions which I am glad to say have outweighed the bad ones.

    I have been with PRR for 3 yrs and I hold a few million. I have traded regularly and the volatility of the SP has allowed me to accummulate steadily.

    PRR theoretically is entirely speculative (no revenue as yet and cash burn rate is high). However, I see less risk with PRR than almost any other bio stock and furthermore a good deal less risk than many resource explorers.

    The PRR journey of the last 3 years is nothing short of compelling. It has been consistent i.e. milestones ticked off as forecast, sometimes exceeded. Unusual compared to other BIOs.

    The science underpinning CVac is clearly leading edge. The clinical risk and efficacy surrounding Cvac is a long way ahead of other potential competing drugs and treatment.

    Now for some some basic commercial principles and questions:

    Is there a worldwide market demand for ovarian cancer treatment? YES

    $ wise - is this world wide demand greater than $3b py? YES

    Is this world wide demand going to grow? YES

    Does PRR's SP accurately reflect its current achieved milestones compared to the journey of other BIOs which have now reached final commercialisation? NO

    At the same journey stage as other successful BIOs is PRR undervalued or overvalued? UNDERVALUED

    In comparison to other commercialised BIOs is PRR demonstrating greater or less potential at its current stage of development? GREATER

    Has PRR got the attention of the super BIOs in the world? YES

    Is PRR an ASX 300 company? YES

    Has PRR got enough cash reserves to operate for the next 2 years? YES

    Does SEC analyse very very carefully companies seeking listing on USA exchanges (NASDAQ)? YES

    Does the FDA consider CVac a potential block buster treatment? YES

    There you have it. DYOR and only take on the investment you can afford. For me PRR is highly likely to provide similar SP results that the dotcom boom provided a few well known Telcos.

    Good luck all and have fun.

    Cheers

    Buster

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.005(1.27%)
Mkt cap ! $569.8M
Open High Low Value Volume
40.0¢ 40.0¢ 39.0¢ $1.746M 4.422M

Buyers (Bids)

No. Vol. Price($)
1 7395 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 94636 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.